Microbiome and Lung Disease: Not So Sterile Anymore!

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".

Deadline for manuscript submissions: closed (30 December 2022) | Viewed by 2049

Special Issue Editor


E-Mail Website
Guest Editor
AstraZeneca, Cambridge, UK
Interests: Inflammation, microbiome, innate immunity

Special Issue Information

Dear Colleagues,

Until recently, the lung was thought of as a sterile organ, protected from pathogens external to the body by the innate and adaptive immune system. When compromised, these defense systems allowed for the invasion of pathogens, leading to acute pneumonia. This paradigm had exceptions, of course. Risk factors such as mechanical ventilation, or genetic diseases including Cystic Fibrosis, increase the risk of bacterial and/or viral infection of the lower airways.

Our understanding of microbial–host interactions, especially in the airway, has evolved significantly over the last ten to fifteen years. We now understand that the lung is not the sterile environment it was originally thought to be. A complex interaction between resident, not just transient, microbes including bacteria, viruses and fungi helps in shaping respiratory function and immune tone. This respiratory microbiome contributes to defense against pathogenic microbes, supports the function of the epithelial barrier and can influence the function of innate and adaptive immune cells. Increasingly, modifications to the airway microbiome have been linked to the development of allergic airway diseases, chronic and frequent exacerbations and rapid decline of lung function.

Dr. Taylor Cohen
Guest Editor

Keywords

  • microbiome
  • respiratory disease
  • immunology
  • metabolome

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 312 KiB  
Review
Bacterial Microbiota of Asthmatic Children and Preschool Wheezers’ Airways—What Do We Know?
by Kamil Bar, Maja Litera-Bar and Barbara Sozańska
Microorganisms 2023, 11(5), 1154; https://doi.org/10.3390/microorganisms11051154 - 28 Apr 2023
Viewed by 1396
Abstract
Asthma is the most chronic pulmonary disease in pediatric population, and its etiopathology still remains unclear. Both viruses and bacteria are suspected factors of disease development and are responsible for its exacerbation. Since the launch of The Human Microbiome Project, there has been [...] Read more.
Asthma is the most chronic pulmonary disease in pediatric population, and its etiopathology still remains unclear. Both viruses and bacteria are suspected factors of disease development and are responsible for its exacerbation. Since the launch of The Human Microbiome Project, there has been an explosion of research on microbiota and its connection with various diseases. In our review, we have collected recent data about both upper- and lower-airway bacterial microbiota of asthmatic children. We have also included studies regarding preschool wheezers, since asthma diagnosis in children under 5 years of age remains challenging due to the lack of an objective tool. This paper indicates the need for further studies of microbiome and asthma, as in today’s knowledge, there is no particular bacterium that discriminates the asthmatics from the healthy peers and can be used as a potential biological factor in the disease prevalence and treatment. Full article
(This article belongs to the Special Issue Microbiome and Lung Disease: Not So Sterile Anymore!)
Back to TopTop